National Drug Schedules

NOTE - Effective December 19, 2013, Schedule F to the Food and Drug Regulationswas repealed and replaced by a list of prescription drugs, called the Prescription Drug List. Therefore, all entries in the National Drug Schedules (NDS) whose footnote indicates that they appear in Schedule F (F1/F2) should now be considered part of the Prescription Drug List (PDL).

Entries whose footnote indicates that they are "Schedule F Recommended" (FR) should now be considered recommended for addition to the PDL. Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS.

For more information on the Prescription Drug List, please consult the Health Canada website.

Drug Product Database
Licensed Natural Health Products Database

Print Friendly Export to CSV

Drug Name	Comment	Schedule	Date
Magnesium citrate	cathartics	III	SEP / 98
Magnesium glutamate hydrobromide^F1		I	SEP / 98
Magnesium salicylate	except oral dosage forms which also contain choline salicylate	III	SEP / 98
Magnesium sulfate	for parenteral use	II	SEP / 98
Magnesium sulfate in injectable form for parenteral nutrition		I	JAN / 03
Manganese and its salts	in injectable form for parenteral nutrition	I	JAN / 03
Mannitol and its salts		II	SEP / 98
Maprotiline and its salts^F1		I	SEP / 98
Maraviroc^F1		I	MAY / 09
Marbofloxacin and its salts and derivatives^F1		I	MAR / 01
Maropitant or its salts^PDL		I	DEC / 13
Mazindol and its salts^TS		I	SEP / 98
Measles vaccine		II	DEC / 98
Mebendazole^F2		I	SEP / 98
Mebolazine^C3		I	JUN / 02
Mecamylamine and its salts^F1		I	SEP / 98
Mechlorethamine and its salts^F1		I	SEP / 98
Meclizine and its salts^F2	when sold in concentrations greater than 25 mg per dosage unit	I	JUL / 00
Meclizine and its salts.	when sold in concentrations of 25 mg or less per dosage unit	III	MAY / 00
Meclofenamic acid and its salts^F1		I	SEP / 98
Mecloqualone and any salt thereof^C5		I	JAN / 03
Medazepam^TS		I	JUN / 02
Medetomidine and its salts^F1		I	MAY / 04
Mefenamic acid and its salts^F1		I	SEP / 98
Mefenorex^TS		I	JUN / 02
Mefloquine and its salts and derivatives^F1		I	SEP / 98
Megestrol and its salts^F1		I	SEP / 98
Melanoma therapeutic vaccine^F1		I	MAR / 01
Melarsomine and its salts^F1	when sold for the treatment of heartworm in dogs	I	MAY / 04
Meloxicam and its salts and derivatives^F1		I	OCT / 03
Melphalan^F1		I	SEP / 98
Memantine and its salts^F1		I	SEP / 06
Meningococcus vaccine		II	MAR / 01
Menotropins^F1	human	I	SEP / 98
Mepacrine and its salts^F1		I	SEP / 98
Mepazine and its salts^F1		I	SEP / 98
Mephenoxalone^F1		I	SEP / 98
Mephentermine and its salts^F1		I	SEP / 98
Mephobarbital^C2		I	JUN / 02
Mepivacaine and its salts	for topical use on mucous membranes, except lozenges	III	SEP / 98
Mepivacaine and its salts	for ophthalmic or parenteral use	II	SEP / 98
Mepolizumab^PDL		I	AUG / 16
Meprobamate^TS		I	SEP / 98
Mepyramine	see pyrilamine	U
Mercaptopurine^F1		I	SEP / 98
Mesabolone^C3		I	JUN / 02
Mesna^F1		I	SEP / 98
Mesocarb and any salt thereof^C4		I	JAN / 03
Mesoridazine and its salts^F1		I	SEP / 98
Mesterolone^C3		I	JUN / 02
Metaldehyde^F1		I	SEP / 98
Metandienone^C3		I	JUN / 02
Metaraminol bitartrate		I	SEP / 98
Metathoheptazine and its salts		II	SEP / 98
Metazocine^N		I	JUN / 02
Metenolone^C3		I	JUN / 02
Metformin and its salts and derivatives^F1		I	SEP / 98
Methabarbital^C2		I	JUN / 02
Methacholine and its salts^F1		I	SEP / 98
Methadone^N		I	JUN / 02
Methamphetamine^C1		I	JUN / 02
Methandriol^C3		I	JUN / 02
Methantheline and its salts		II	SEP / 98
Methaqualone^C1		I	JUN / 02
Methazolamide and its salts^F1		I	MAY / 00
Methdilazine and its salts		II	SEP / 98
Methenamine and its salts	except for topical use	II	SEP / 98
Metheptazine and its salts		II	SEP / 98
Methimazole^F1		I	SEP / 98
Methisazone^F1		I	SEP / 98
Methocarbamol	for parenteral use	II	SEP / 98
Methocarbamol.	except for parenteral use	III	SEP / 98
Methoin^F1	Mephenytoin and its salts	I	SEP / 98
Methotrexate and its salts^F1		I	SEP / 98
Methotrimeprazine and its salts^F1		I	SEP / 98
Methoxamine and its salts^F1		I	SEP / 98
Methoxsalen^F1		I	SEP / 98
Methoxy polyethylene glycol-epoetin beta^F1		I	OCT / 09
Methoxyflurane^PDL		I	MAY / 18
Methyl salicylate	in liquid dosage forms in concentrations greater than 30%	II	SEP / 98
Methyl salicylate.	in liquid dosage forms in concentrations up to and including 30%	U
Methyldesorphine^N		I	JUN / 02
Methyldihydromorphine^N		I	JUN / 02
Methyldopa and its salts^F1		I	SEP / 98
Methylene Blue	for parenteral use	II	SEP / 98
Methylparafynol^F1		I	SEP / 98
Methylphenidate^C1		I	JUN / 02
Methylphenobarbital^C2		I	JUN / 02
Methylphenylisonipecotonitrile^N		I	JUN / 02
Methyltestosterone^C3		I	JUN / 02
Methyprylon^TS		I	SEP / 98
Methysergide and its salts and derivatives^F1		I	SEP / 98
Metoclopramide^F1		I	SEP / 98
Metolazone and its salts^F1		I	SEP / 98
Metomidate and its salts^F1		I	SEP / 98
Metopimazine and its salts^F1		I	SEP / 98
Metopon^N		I	JUN / 02
Metoprolol and its salts^F1		I	SEP / 98
Metribolone^C3		I	JUN / 02
Metronidazole^F1		I	SEP / 98

141 result(s)

Print Friendly Export to CSV

Footnotes

C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
C4: drug is in the Controlled Drugs and Substances Act
C5: drug is in the Regulations Under CDSA
CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR: drug has not been reviewed by NDSAC
PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
U: drug has been reviewed by NDSAC and is unscheduled

National Drug Schedules

Search: National Drug Schedules

141 result(s)

Footnotes